The Latest Cardiac and Vascular News
TEL AVIV, Israel, March 5, 2019 /PRNewswire/ — Vascular Graft Solutions Ltd. (VGS) announces the completion of patient enrollment in the company’s US Investigational Device Exemption (IDE) randomized, controlled pivotal study, evaluating the efficacy of the VEST external support for saphenous vein grafts in coronary artery bypass (CABG) surgery. The study enrolled 224 patients at 17 clinical sites […]
TEL AVIV, Israel, April 23, 2018 /PRNewswire/ — Vascular Graft Solutions Ltd (VGS) announces on enrollment of the first 20 patients into the VEST US pivotal trial that will evaluate the safety and effectiveness of the VEST, a novel external support device for treatment of saphenous vein graft disease after coronary artery bypass grafting (CABG). “After more […]
